Previous 10 | Next 10 |
2024-02-27 08:53:47 ET DENVER, Colo., Feb 27, 2024 ( 247marketnews.com )- Hims & Hers Health, Inc. (NYSE: HIMS ) reported, after yesterday’s market close, financial results for the fourth quarter and full year 2023 financial results, and upbeat guidance for 2024. Resu...
Revenue of $872.0 million, up 65% year-over-year in 2023 Net income of $1.2 million; Adjusted EBITDA profitability of $20.6 million in Q4 2023 Subscribers grew to 1.5 million, up 48% year-over-year in Q4 2023 Provides Q1 and full year 2024 guidance, with full year 2024 rev...
SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...
2024-02-25 08:00:00 ET The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce ( NYSE: CRM ), Snowflake ( NYSE: SNOW ), Zoom Video Communications ( NASD...
2024-02-25 06:20:33 ET Summary Hims & Hers Health stock has rallied over 50% since our previous "Strong Buy" article, but the stock may be overextended, and earnings are approaching. The company's subscription model, market opportunity, and undervalued multiple were the main r...
2024-02-23 17:35:52 ET More on Him & Hers Health Unlocking Growth: Why Hims & Hers Stock Is A Very Compelling Buy In 2024 Hims & Hers Health: No Clear Moat Besides First Mover Advantage Hims & Hers Health: Unleashing Macro Momentum - Investing In Grow...
2024-02-21 15:26:22 ET More on Teladoc Health Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation Teladoc: Should Investors Wait For Its Uncertain Turnaround Story? Teladoc Health, Inc. (TDOC) Q4 2023 Earnings Call Transcript Biggest stock mover...
Longtime company leader ensures the brand is innovating and driving a digital-first, personalized health and wellness experience. Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join th...
2024-02-06 10:52:01 ET More on Consumer Staples Philip Morris least short consumer staples stock; Campbell Soup is most short Dividend scorecard for Consumer Staples Select Sector SPDR ETF Read the full article on Seeking Alpha For further details see: GO...
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024. The company will host a live conference call to dis...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...